Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare. The fourth-leading cause of death is drug side effects, and drugs only work half the time, says Hrusovsky. He believes that if you can personalize the drugs, you have an opportunity to improve the whole pharmaceutical industry. Quanterix is developing technology that will digitize how they see into blood, and help to see disease long before there are symptoms. Rocket science is being deployed into the blood, says Hrusovsky. He says that if you can see biomarkers and incorporate into fitbits, it can really help improve health.

Share:
More In Science
Arctic Blast Hits Northeast
An arctic blast is hitting the Northeast as millions are dealing with wind chills that could hit as low as 60 below zero.
Atomos Developing Space Propulsion Vehicles to Reposition Satellites
Aerospace startup Atomos Space, which is developing a series of orbital transfer vehicles to help reposition satellites in space, recently closed on a $16 million financing round. CEO Vanessa Clark and COO William Kowalski joined Cheddar News to discuss the company's operations ahead of its launch.
Need2Know: January 31, 2023
First responders fired after video of police beating Tyre Nichols was released, 10 people show in Lanland, Fla. and winter storm is causing travel troubles. Here is everything you Need2Know for January 31, 2023.
Load More